During the past decade, IMSP Institutul de Medicina Urgenta conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 2 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "IMSP Institutul de Medicina Urgenta" are "Multiple Sclerosis" (2 trials), "Intoxication" (1 trials), "Intoxication; Septic" (1 trials), "Peritonitis" (1 trials) and "Relapsing Multiple Sclerosis" (1 trials). Many other conditions were trialed in "IMSP Institutul de Medicina Urgenta" in a lesser frequency.

Most popular intervention types in "IMSP Institutul de Medicina Urgenta" are "Drug" (5 trials). Other intervention types were less common.

The name of intervention was led by "Interferon beta-1a" (2 trials), "Ozanimod" (2 trials), "Rheosorbilact®" (2 trials), "Ringer lactate" (2 trials) and "Interferon beta-1a placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "IMSP Institutul de Medicina Urgenta" are 5 trials for "All" genders.

Currently, there are NaN active trials in "IMSP Institutul de Medicina Urgenta". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in IMSP Institutul de Medicina Urgenta, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in IMSP Institutul de Medicina Urgenta, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".